Development and biocompatibility of a novel corrodible fluoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Andreas Drynda
  • Thomas Hassel
  • René Hoehn
  • Angela Perz
  • Friedrich Wilhelm Bach
  • Matthias Peuster

Organisationseinheiten

Externe Organisationen

  • Universität Rostock
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)763-775
Seitenumfang13
FachzeitschriftJournal of Biomedical Materials Research - Part A
Jahrgang93
Ausgabenummer2
Frühes Online-Datum3 Aug. 2009
PublikationsstatusVeröffentlicht - Mai 2010

Abstract

Recently, corrodible magnesium-based alloys have been introduced for use as cardiovascular stents and orthopedic implants. However, rapid corrosion rates have raised questions about their biocompatibility. Therefore, we developed a binary fluoride-coated magnesium-calcium alloy with improved degradation kinetics. Biocompatibility of the alloys was evaluated with metabolic assays (colorimetric WST-1 test). Furthermore, five different probes of magnesium-calcium alloys (MgCa 0.4, 0.6, 0.8, 1.2, and 2.0 wt %) were cocultivated with human smooth muscle cells and endothelial cells. To investigate the decomposition kinetics in a physiological environment the alloys were used untreated and fluoride coated (MgF2). Mg and Ca decreased the metabolic activity in vascular cells dosedependently, with cytotoxic effects only at unphysiological concentrations. Uncoated magnesium alloys showed signs of decomposition after a short incubation time of 24 h in contrast to MgF 2 coated alloys. After 10 days smooth muscle and endothelial cells around the alloys were still alive, whereas colonization of the surfaces was only observed for smooth muscle cells. The fluoride-coated MgCa alloys exhibited good results concerning mechanical properties, degradation kinetics, and biocompatibility in vitro. We conclude that a binary fluoride magnesium-calcium alloy is a promising candidate for the production of cardiovascular stents.

ASJC Scopus Sachgebiete

Zitieren

Development and biocompatibility of a novel corrodible fluoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications. / Drynda, Andreas; Hassel, Thomas; Hoehn, René et al.
in: Journal of Biomedical Materials Research - Part A, Jahrgang 93, Nr. 2, 05.2010, S. 763-775.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Download
@article{168ceac548454421a1f83ce823da8fab,
title = "Development and biocompatibility of a novel corrodible fluoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications",
abstract = "Recently, corrodible magnesium-based alloys have been introduced for use as cardiovascular stents and orthopedic implants. However, rapid corrosion rates have raised questions about their biocompatibility. Therefore, we developed a binary fluoride-coated magnesium-calcium alloy with improved degradation kinetics. Biocompatibility of the alloys was evaluated with metabolic assays (colorimetric WST-1 test). Furthermore, five different probes of magnesium-calcium alloys (MgCa 0.4, 0.6, 0.8, 1.2, and 2.0 wt %) were cocultivated with human smooth muscle cells and endothelial cells. To investigate the decomposition kinetics in a physiological environment the alloys were used untreated and fluoride coated (MgF2). Mg and Ca decreased the metabolic activity in vascular cells dosedependently, with cytotoxic effects only at unphysiological concentrations. Uncoated magnesium alloys showed signs of decomposition after a short incubation time of 24 h in contrast to MgF 2 coated alloys. After 10 days smooth muscle and endothelial cells around the alloys were still alive, whereas colonization of the surfaces was only observed for smooth muscle cells. The fluoride-coated MgCa alloys exhibited good results concerning mechanical properties, degradation kinetics, and biocompatibility in vitro. We conclude that a binary fluoride magnesium-calcium alloy is a promising candidate for the production of cardiovascular stents.",
keywords = "Biocorrosion, Calcium, Fluorine-fluoride, Intravascular stent, Magnesium",
author = "Andreas Drynda and Thomas Hassel and Ren{\'e} Hoehn and Angela Perz and Bach, {Friedrich Wilhelm} and Matthias Peuster",
year = "2010",
month = may,
doi = "10.1002/jbm.a.32582",
language = "English",
volume = "93",
pages = "763--775",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "Heterocorporation",
number = "2",

}

Download

TY - JOUR

T1 - Development and biocompatibility of a novel corrodible fluoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications

AU - Drynda, Andreas

AU - Hassel, Thomas

AU - Hoehn, René

AU - Perz, Angela

AU - Bach, Friedrich Wilhelm

AU - Peuster, Matthias

PY - 2010/5

Y1 - 2010/5

N2 - Recently, corrodible magnesium-based alloys have been introduced for use as cardiovascular stents and orthopedic implants. However, rapid corrosion rates have raised questions about their biocompatibility. Therefore, we developed a binary fluoride-coated magnesium-calcium alloy with improved degradation kinetics. Biocompatibility of the alloys was evaluated with metabolic assays (colorimetric WST-1 test). Furthermore, five different probes of magnesium-calcium alloys (MgCa 0.4, 0.6, 0.8, 1.2, and 2.0 wt %) were cocultivated with human smooth muscle cells and endothelial cells. To investigate the decomposition kinetics in a physiological environment the alloys were used untreated and fluoride coated (MgF2). Mg and Ca decreased the metabolic activity in vascular cells dosedependently, with cytotoxic effects only at unphysiological concentrations. Uncoated magnesium alloys showed signs of decomposition after a short incubation time of 24 h in contrast to MgF 2 coated alloys. After 10 days smooth muscle and endothelial cells around the alloys were still alive, whereas colonization of the surfaces was only observed for smooth muscle cells. The fluoride-coated MgCa alloys exhibited good results concerning mechanical properties, degradation kinetics, and biocompatibility in vitro. We conclude that a binary fluoride magnesium-calcium alloy is a promising candidate for the production of cardiovascular stents.

AB - Recently, corrodible magnesium-based alloys have been introduced for use as cardiovascular stents and orthopedic implants. However, rapid corrosion rates have raised questions about their biocompatibility. Therefore, we developed a binary fluoride-coated magnesium-calcium alloy with improved degradation kinetics. Biocompatibility of the alloys was evaluated with metabolic assays (colorimetric WST-1 test). Furthermore, five different probes of magnesium-calcium alloys (MgCa 0.4, 0.6, 0.8, 1.2, and 2.0 wt %) were cocultivated with human smooth muscle cells and endothelial cells. To investigate the decomposition kinetics in a physiological environment the alloys were used untreated and fluoride coated (MgF2). Mg and Ca decreased the metabolic activity in vascular cells dosedependently, with cytotoxic effects only at unphysiological concentrations. Uncoated magnesium alloys showed signs of decomposition after a short incubation time of 24 h in contrast to MgF 2 coated alloys. After 10 days smooth muscle and endothelial cells around the alloys were still alive, whereas colonization of the surfaces was only observed for smooth muscle cells. The fluoride-coated MgCa alloys exhibited good results concerning mechanical properties, degradation kinetics, and biocompatibility in vitro. We conclude that a binary fluoride magnesium-calcium alloy is a promising candidate for the production of cardiovascular stents.

KW - Biocorrosion

KW - Calcium

KW - Fluorine-fluoride

KW - Intravascular stent

KW - Magnesium

UR - http://www.scopus.com/inward/record.url?scp=77950219251&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.32582

DO - 10.1002/jbm.a.32582

M3 - Article

C2 - 19653306

AN - SCOPUS:77950219251

VL - 93

SP - 763

EP - 775

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 2

ER -